Frequently searched
↑ ↓ to move · Enter to open · Esc to closeSynonyms and typos are matched
Trial site
Recruiting
A Single Dose, Dose Escalation Clinical Trial on the Safety, Tolerability and Efficacy of Lyophilized Powder for Inhalation of Recombinant Human Keratinocyte Growth Factor-2 (Rh-KGF-2) in The Treatment of Patients With Acute Respiratory Distress Syndrome
NCT07558538· Early phase 1· Shanghai Zhongshan Hospital· Source
Contact: Yi Wei
Site data: ClinicalTrials.govUpdated 12 Nov 2026
Report an error